In a recent study published in Scientific Reports, researchers reported that drug adsorption on micro- and nano-plastics (MNPs) has severe consequences.
Introduction
Plastic degradation results in the formation of particles with diverse shapes, sizes, and compositions. Research suggests these micro- and nano-sized fragments, viz., MNPs, are present in the environment and enter the human body, even cells.
MNPs can adsorb different substances and deliver them to living organisms. Endocrine disruptors are among the compounds that enter life forms and trigger toxic effects.
Residual drugs in wastewater could enter the human and animal bodies, causing physiological changes. This is particularly concerning in the case of antimicrobials; bacteria exposed to these compounds may develop resistance.
Further, the abundance of resistance genes has increased due to the continuous anthropogenic use (or misuse) of antimicrobials. Besides, MNPs provide a surface for microbes to colonize, serving as vectors for transmission.
About the study
In the present study, researchers assessed the interactions of tetracycline (TC), a broad-spectrum antibiotic, with nanoplastics and whether its biological activity is altered.
Four types of plastics were selected: polystyrene (PS), polyethylene (PE), nylon 6,6 (N66), and polypropylene (PP); these were henceforth referred to as NPs instead of MNPs because their sizes did not exceed the nanoscale. Two approaches were employed to generate TC-NP complexes through chemical computation.
First, the NP was folded from individual polymer chains in the presence of TC through multiple simulated annealing (SA) setups. In the second approach, the free particle (FP) method, the NP was pre-folded through SA, and TC was placed on its surface in different orientations.
All conformations underwent geometry optimization. Further, semi-empirical quantum chemical calculations were performed, and sorption energies and binding modes were derived from these calculations.
Two molecular dynamics simulations were performed for each NP to analyze the solvation behavior and temperature influence of the TC-NP aggregates.
Finally, the researchers evaluated the effects of plastic particles (PE terephthalate (PET), PS, or PE) on the activity of TC in mouse and human cell lines, in which the expression of a fluorescent reporter protein was regulated by a TC-controlled promoter.
Findings
The FP and SA approaches generated 104 aggregates for each NP. The relative total energies of the structures were variable. FP data scattered less since these conformer aggregates varied exclusively in their surface structure. Scattering was the lowest for PE but the highest for PS and PP.
The refolding of TC-NP complexes in the SA method allowed for adjusting the polymer chains to TC and selecting the best possible conformation to maximize the sum of NP-TC and NP-NP interplay.
The FP method yielded considerably less stable structures compared to the SA approach. Overall, the SA approach performed better than the FP method.
On PE, the less polar side of TC was attached to the NP, and the hydroxyl, amide, and carbonyl groups were pointed toward the aqueous solvent. In contrast, on N66, TC alignment was the opposite, and the polar-polar interactions between TC and N66 were stronger than their solvation.
In the SA method, TC was often inside the NP, buried beneath the polymer chains. Further, molecular dynamics simulations of two TC-NP structures of each plastic in water revealed significant differences in the mobilities of the NP chains.
PS chains were the least mobile, with the largest functional groups attached to their polyolefin backbone that may provide steric hindrance or friction.
Likewise, N66 movement was also hindered due to the strong hydrogen bonds between amide groups. The rearrangement of PP was remarkable, with nearly two times greater deviations than the starting structures, suggesting it could rearrange enough to accommodate TC within.
Further, TC diffused significantly on the top of N66 and PP particles. While TC detached from PS during equilibration, it re-attached over time.
In simulations starting with TC on the surface of NPs, the number of hydrogen bonds was high, with many hydrogen-bond acceptor and donor sites occupied with a water molecule.
In contrast, there were significant differences in simulations that started with TC inside the NPs. PS and N66 retained the drug molecule inside them; as such, the hydrogen bonding sites of TC were inaccessible to water molecules.
Moreover, N66 hydrogen bonding sites can interact with TC; thus, they compete with water for the antibiotic. For PP and PE, the number of hydrogen bonds between TC and water was high, similar to those in simulations with TC on the surface of NPs.
Finally, incubating cells with PS, PE, or PET significantly reduced TC-induced expression of the fluorescent reporter protein in both cell lines.
Conclusions
Taken together, the study investigated the interactions of NPs with TC. Folding the NPs in the presence of TC resulted in high-energy structures, enabling reorientation and adjustment of polymer chains to the drug. The SA method yielded the most stable TC-NP complexes. Moreover, TC was more often situated inside the NPs.
Further, in vitro experiments showed that the effect of TC was significantly reduced in the presence of plastics. Overall, the findings indicate that MNPs pose substantial health risks, as they may alter drug absorption, facilitate drug transport to new locations, and increase local concentrations of the antibiotic, potentially promoting resistance.
- Dick L, Batista PR, Zaby P, et al. (2024) The adsorption of drugs on nanoplastics has severe biological impact. Scientific Reports. doi: 10.1038/s41598-024-75785-4. https://www.nature.com/articles/s41598-024-75785-4
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]















